Anavex Life Sciences
N/A
USD
N/A
N/A
...
Chart
Financials
Description
AVXL Company Description
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.
AVXL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view AVXL Smart Score
Score Breakdown
AVXL Company Description
Show More
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of AVXL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AVXL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on AVXL's company Twitter account
WallStreetBets
Number of mentions of AVXL in WallStreetBets Daily Discussion
AVXL News
Recent insights relating to AVXL
CNBC Recommendations
Recent picks made for AVXL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in AVXL
Corporate Flights
Flights by private jets registered to AVXL
Our Analysis